欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号AT/H/0793/001
药品名称Fulvestrant EVER Pharma 250 mg solution for injection in pre-filled syringe
活性成分
    • fulvestrant 250.0 mg
剂型Solution for injection in pre-filled syringe
上市许可持有人EVER Valinject GmbH Oberburgau 3, 4866 Unterach am Attersee, Austria
参考成员国 - 产品名称Austria (AT)
Fulvestrant EVER Pharma 250 mg Injektionslösung in einer Fertigspritze
互认成员国 - 产品名称
    • Germany (DE)
      Fulvestrant EVER Pharma 250 mg Injektionslösung in einer Fertigspritze
    • Denmark (DK)
    • Netherlands (NL)
    • United Kingdom (Northern Ireland) (XI)
    • France (FR)
    • Spain (ES)
    • Italy (IT)
    • Poland (PL)
      Dacepton
    • Hungary (HU)
      FULVESTRANT EVER PHARMA 250 mg oldatos injekció előretöltött fecskendőben
    • Czechia (CZ)
      Fulvestrant EVER Pharma 250 mg injekční roztok v předplněné injekční stříkačce
    • Romania (RO)
    • Slovakia (SK)
    • Croatia (HR)
      Fulvestrant EVER Pharma 250 mg otopina za injekciju u napunjenoj štrcaljki
    • Belgium (BE)
    • Bulgaria (BG)
    • Finland (FI)
    • Greece (GR)
    • Ireland (IE)
    • Norway (NO)
    • Portugal (PT)
    • Slovenia (SI)
    • Sweden (SE)
许可日期2018/09/03
最近更新日期2024/03/27
药物ATC编码
    • L02BA03 fulvestrant
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase